Lior Carmon

571 total citations
27 papers, 466 citations indexed

About

Lior Carmon is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Lior Carmon has authored 27 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 17 papers in Molecular Biology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Lior Carmon's work include Immunotherapy and Immune Responses (17 papers), vaccines and immunoinformatics approaches (10 papers) and Immune Cell Function and Interaction (9 papers). Lior Carmon is often cited by papers focused on Immunotherapy and Immune Responses (17 papers), vaccines and immunoinformatics approaches (10 papers) and Immune Cell Function and Interaction (9 papers). Lior Carmon collaborates with scholars based in Israel, France and South Korea. Lior Carmon's co-authors include Riva Kovjazin, Lea Eisenbach, Boaz Tirosh, Khaled El‐Shami, Erez Bar‐Haim, Mati Fridkin, Michaël Feldman, Ezra Vadai, Galit Horn and Nechama I. Smorodinsky and has published in prestigious journals such as Journal of Clinical Investigation, Blood and PLoS ONE.

In The Last Decade

Lior Carmon

23 papers receiving 443 citations

Peers

Lior Carmon
Anne‐Laure Puaux France
Yuval Elhanati United States
Heike Danzer Germany
Casey A. Carlos United States
Nili Tickotsky Israel
Shirley Sian United States
Susanne Bergstedt‐Lindqvist Sweden
Giso Brasser Netherlands
E Braakman Netherlands
Karoline W. Schjetne Norway
Anne‐Laure Puaux France
Lior Carmon
Citations per year, relative to Lior Carmon Lior Carmon (= 1×) peers Anne‐Laure Puaux

Countries citing papers authored by Lior Carmon

Since Specialization
Citations

This map shows the geographic impact of Lior Carmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lior Carmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lior Carmon more than expected).

Fields of papers citing papers by Lior Carmon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lior Carmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lior Carmon. The network helps show where Lior Carmon may publish in the future.

Co-authorship network of co-authors of Lior Carmon

This figure shows the co-authorship network connecting the top 25 collaborators of Lior Carmon. A scholar is included among the top collaborators of Lior Carmon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lior Carmon. Lior Carmon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carmon, Lior, Marina Eskin‐Schwartz, Ohad S. Birk, et al.. (2022). Hypoparathyroidism-retardation-dysmorphism syndrome—Clinical insights from a large longitudinal cohort in a single medical center. Frontiers in Pediatrics. 10. 916679–916679.
2.
Latzer, Itay Tokatly, et al.. (2021). Failure of Israeli pediatric residency curricula to cover child development and special education issues: results of a national survey on levels of knowledge. Israel Journal of Health Policy Research. 10(1). 33–50. 1 indexed citations
3.
Goldbart, Aviv, Inbal Golan‐Tripto, Giora Pillar, et al.. (2020). Inhaled nitric oxide therapy in acute bronchiolitis: A multicenter randomized clinical trial. Scientific Reports. 10(1). 9605–9605. 20 indexed citations
4.
Loewenthal, Neta, et al.. (2020). Multiple Endocrine Deficiencies are Common in Hypoparathyroidism–Retardation–Dysmorphism Syndrome. The Journal of Clinical Endocrinology & Metabolism. 106(2). e907–e916. 3 indexed citations
5.
Kovjazin, Riva, Galit Horn, Nechama I. Smorodinsky, Michal Shapira, & Lior Carmon. (2014). Cell Surface-Associated Anti-MUC1-Derived Signal Peptide Antibodies: Implications for Cancer Diagnostics and Therapy. PLoS ONE. 9(1). e85400–e85400. 20 indexed citations
6.
Carmon, Lior, Irit Avivi, Riva Kovjazin, et al.. (2014). Phase I/II study exploring ImMucin, a pan‐major histocompatibility complex, anti‐MUC1 signal peptide vaccine, in multiple myeloma patients. British Journal of Haematology. 169(1). 44–56. 49 indexed citations
7.
8.
Kovjazin, Riva, David Shitrit, Rachel Preiss, et al.. (2013). Characterization of Novel Multiantigenic Vaccine Candidates with Pan-HLA Coverage against Mycobacterium tuberculosis. Clinical and Vaccine Immunology. 20(3). 328–340. 10 indexed citations
9.
10.
Kovjazin, Riva, Galit Horn, Nechama I. Smorodinsky, et al.. (2012). Autoantibodies against the signal peptide domain of MUC1 in patients with multiple myeloma: Implications for disease diagnosis and prognosis. Experimental and Therapeutic Medicine. 3(6). 1092–1098. 7 indexed citations
11.
Kovjazin, Riva, Ilan Volovitz, Yulia Kundel, et al.. (2011). ImMucin: A novel therapeutic vaccine with promiscuous MHC binding for the treatment of MUC1-expressing tumors. Vaccine. 29(29-30). 4676–4686. 34 indexed citations
12.
13.
Tirosh, Boaz, Lior Carmon, Aviv Paz, et al.. (2007). ‘1-8 interferon inducible gene family’: putative colon carcinoma-associated antigens. British Journal of Cancer. 97(12). 1655–1663. 9 indexed citations
14.
Bar‐Haim, Erez, Aviv Paz, Arthur Machlenkin, et al.. (2004). MAGE-A8 overexpression in transitional cell carcinoma of the bladder: identification of two tumour-associated antigen peptides. British Journal of Cancer. 91(2). 398–407. 19 indexed citations
15.
Carmon, Lior, Baruch Brenner, Adrian Paz, et al.. (2002). Characterization of novel breast carcinoma–associated BA46-derived peptides in HLA-A2.1/Db-β2mtransgenic mice. Journal of Clinical Investigation. 110(4). 453–462. 30 indexed citations
16.
El‐Shami, Khaled, Boaz Tirosh, Dan Popovic, et al.. (2000). Induction of antitumor immunity by proteasome-inhibited syngeneic fibroblasts pulsed with a modified TAA peptide. International Journal of Cancer. 85(2). 236–236.
17.
El‐Shami, Khaled, Boaz Tirosh, Lior Carmon, et al.. (2000). Induction of antitumor immunity by proteasome-inhibited syngeneic fibroblasts pulsed with a modified TAA peptide. International Journal of Cancer. 85(2). 236–242. 13 indexed citations
18.
El‐Shami, Khaled, Boaz Tirosh, Erez Bar‐Haim, et al.. (1999). MHC class I-restricted epitope spreading in the context of tumor rejection following vaccination with a single immunodominant CTL epitope. European Journal of Immunology. 29(10). 3295–3301. 77 indexed citations
19.
Tirosh, Boaz, Khaled El‐Shami, Nora Vaisman, et al.. (1999). Immunogenicity of H-2Kb-low affinity, high affinity, and covalently-bound peptides in anti-tumor vaccination. Immunology Letters. 70(1). 21–28. 12 indexed citations
20.
Smorodinsky, Nechama I., Ronit I. Yarden, Lior Carmon, et al.. (1994). Vaccination Against Breast Cancer — Studies in an Animal Model. Advances in experimental medicine and biology. 353. 125–137.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anne‐Laure Puaux Breakdown of academic impact, for papers by Yuval Elhanati Breakdown of academic impact, for papers by Heike Danzer Breakdown of academic impact, for papers by Casey A. Carlos Breakdown of academic impact, for papers by Nili Tickotsky Breakdown of academic impact, for papers by Shirley Sian Breakdown of academic impact, for papers by Susanne Bergstedt‐Lindqvist Breakdown of academic impact, for papers by Giso Brasser Breakdown of academic impact, for papers by E Braakman Breakdown of academic impact, for papers by Karoline W. Schjetne
Rankless by CCL
2026